comparemela.com

Latest Breaking News On - Ceo interview - Page 15 : comparemela.com

RIV Capital CEO Narbe Alexandrian on Shopping for US Cannabis Deals

RIV Capital CEO Narbe Alexandrian said he's looking to make a splash in the US cannabis market by acquiring companies.

How Mike Meldman Got the Rich and Famous to Live in Resorts

His exclusive Discovery Land clubs, with $50 million homes and over-the-top amenities, lure celebrity members like Ben Affleck and Jennifer Lopez. (Yes, together.)

Coursera CEO: We Help People Learn New Skills for Digital Jobs

Coursera During the pandemic, Coursera s revenue more than doubled. CEO Jeff Maggioncalda credits the accessibility and flexibility of its programs. Now the platform wants to help learners switch careers. Late last February, after Japan s prime minister closed every school in the country due to a novel respiratory infection that beset the region, Jeff Maggioncalda made a prediction. Maggioncalda, the CEO of the online-learning platform Coursera, was on his way to an airport in Texas after visiting Rice University. But before boarding his flight to Utah, he sent an email to his staff. Team, the email read, Japan just closed every school in their country. I think this thing is going to become a pandemic, and all the schools in the world are going to close. We need to start working on this.

Baladna CEO Exclusive Part I: Portfolio innovation and forward planning key to surviving and thriving says dairy giant

Qatar dairy giant Baladna’s CEO Malcolm Jordan has revealed the firm’s secrets to surviving and thriving amidst the COVID-19 pandemic as the early implementation of operational improvements and being quick to innovate in its product portfolio.

BridgeBio: Biotech inspired by Andrew Lo gets treatment FDA approved

This story is available exclusively to Insider subscribers. Become an Insider and start reading now. The FDA approved BridgeBio s first drug, for a disease that affects 100 children in the US and Europe. BridgeBio mitigates risk with a hub-and-spoke model, with a central management team and subsidiaries. The model is gaining in popularity in biopharma and could reshape drug R&D, McKinsey & Co. says. It wasn t that long ago that the idea behind BridgeBio drew laughter from biotech and finance experts.  But these days, CEO Neil Kumar says he s taking calls from industry insiders interested in launching companies emulating the BridgeBio model. If it helps patients, he s willing to guide rivals. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.